NovoHeart
Pre-clinicalNovoheart is a global stem cell biotechnology firm dedicated to engineering bioartificial human heart surrogates using stem cell and bioengineering.
Founded
2014
Focus
Regenerative MedicineCardiovascular
About
Novoheart is a global stem cell biotechnology firm dedicated to engineering bioartificial human heart surrogates using stem cell and bioengineering.
Funding History
3Total raised: $25.5M
Series B$15MUndisclosedMar 15, 2020
Series A$8MUndisclosedSep 15, 2017
Seed$2.5MUndisclosedJun 15, 2015
Company Info
TypePrivate
Founded2014
LocationHong Kong, United States
StagePre-clinical
Contact
SIMILAR COMPANIES
BASi Research Products
Pre-clinical · West Lafayette
Bay BioSciences
Pre-clinical · San Francisco
EydisBio
Pre-clinical · Cambridge
3Spine
Pre-clinical · Memphis
Belcher Pharmaceuticals
Pre-clinical · Miami
Is this your company?
Claim your profile to update information, add pipeline data, and connect with investors.
Claim profile